drugset / Trial / NCT01874340
Efficacy and Safety of AIN457 (Secukinumab) in Patients With Relapsing Multiple Sclerosis
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the efficacy and safety of AIN457 versus placebo in patients with relapsing multiple sclerosis.
Timeline
- Start
- 2013-06
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Secukinumab | Monoclonal antibody | — | Intravenous |